SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
GZMO
An SI Board Since November 1998
Posts SubjectMarks Bans Symbol
438 23 0 GZMO
Emcee:  mike mulhearn Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
438Genzyme annual report indicates that phase I/II Kidney cancer vacine results wilExtra Pale-5/3/2004
437>>FRAMINGHAM, Mass., Jan. 9 /PRNewswire-FirstCall/ -- Genzyme Molecular Ontuck-1/9/2003
436>>FRAMINGHAM, Mass., Dec. 10 /PRNewswire-FirstCall/ -- A team of Harvard Mtuck-12/10/2002
435>>FRAMINGHAM, Mass., Oct. 29 /PRNewswire-FirstCall/ -- In a scientific joutuck-10/29/2002
434FRAMINGHAM, Mass., Oct. 16 /PRNewswire-FirstCall/ -- Genzyme Corp. today reportenigel bates-10/16/2002
433Thanks for the dddmag pointer, Tuck. Parking the two Silico Insights PRs for funigel bates-10/14/2002
432Besides plain old borning cash, now would be an excellent time for Genzyme to buMike McFarland-10/12/2002
431One has to wonder if a little love ($) from Papa Genzyme might do wonders for thtuck-10/11/2002
430GZMO price is deteriorating again it seems, I nibbled on some over the past couMike McFarland-9/12/2002
429GZMO is about the only biotech I managed to sell at the right time (well into donigel bates-8/27/2002
428Another shameless hype laden PR--dripping with scientific goo, or is there sometMike McFarland-8/27/2002
427FRAMINGHAM, Mass., Aug. 27 /PRNewswire-FirstCall/ -- A new, rapid method of idennigel bates-8/27/2002
426I like GZMO's tech. Have been buying all the way down and getting crushed. SOROS-5/23/2002
425GZMO continues to crater on lowish volume; now ~1.5x cash. >>FRAMINGHAM, tuck-5/20/2002
424New Genomics Method Likely to Accelerate Completion of the Human Genome FRAMINGnigel bates-5/6/2002
423EP, This abstract appears to be the one referenced, but was published in Novembtuck-4/3/2002
422Tuesday April 2, 4:21 pm Eastern Time Press Release SOURCE: Genzyme Molecular OnExtra Pale-4/2/2002
421GZMO within a hair's breadth of lows, since the release of this earnings reptuck-3/21/2002
420>>FRAMINGHAM, Mass., Jan. 15 /PRNewswire-FirstCall/-- Genzyme Molecular Ontuck-1/15/2002
419Monday January 14, 9:16 am Eastern Time Press Release SOURCE: Genzyme Molecular Extra Pale-1/14/2002
418<< ExtraPale, my background is finance - note this post of mine from YahooSpekulatius-1/6/2002
417ExtraPale, my background is finance - note this post of mine from Yahoo which pujeffbas-1/6/2002
416The $32million boosted my declining view of gzmo/genz - with no way of knowing, Extra Pale-1/6/2002
415I do not trust GENZ either. They have huge conflicts of interest in managing thejeffbas-1/5/2002
414p53 article (thanks, Savant) msnbc.comExtra Pale-1/3/2002
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News